Search results
Alembic Pharma gains nearly 5% on tentative USFDA nod for leukemia drug - CNBC TV18
CNBC TV18· 3 days agoIn a filing to the stock exchanges, the company said that it has received tentative approval from...
Alembic Pharma stock rallies 5% after firm receives USFDA tentative approval for Bosutinib tablets
CNBC Awaaz· 3 days agoAlembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration...